Primary sources first
Regulatory records, full papers, trial registrations, filings and direct documentation outrank summaries and press releases.
These rules govern every alert, article, analysis and update. Speed never suspends them.
Regulatory records, full papers, trial registrations, filings and direct documentation outrank summaries and press releases.
Cell and animal results are labeled preclinical. Biomarkers are not presented as proof of longer life or better health.
We do not publish personalized protocols, dosing instructions or sourcing directions for unapproved products.
Sample size, study design, conflicts, endpoint relevance and uncertainty appear beside the claim—not buried below it.
AI may monitor, research, organize sources and write articles. Publisher-authorized automation may publish after the documented sourcing, length, chronology and evidence gates pass.
Sponsors, affiliate relationships, investor positions, gifts and material conflicts are disclosed. Commercial partners do not preview coverage.
AI can find candidate stories, assemble source packets, create claim ledgers and write original articles. Publisher-authorized automation may publish without prepublication human review when the article passes the newsroom's sourcing, chronology, originality, evidence-labeling and minimum-length gates. The article record identifies that review state. AI may not invent interviews, conceal uncertainty, convert animal evidence into human advice, or present an unreviewed article as medically approved.